{'fraction_non_alphanumeric': 0.014040561622464899, 'fraction_numerical': 0.0, 'mean_word_length': 5.6875, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Nonoperative management of patients with carcinoma metastatic to bone

The skeleton is the most common site of metastatic spread of cancer and a leading cause of morbidity and mortality from cancer. Treatment of bone metastases can lead to improvement in survival and quality of life. Because bone metastases usually are widespread by the time they become symptomatic, nonoperative management options play an integral role in their treatment. Potential treatment options for carcinoma metastatic to bone include bone-targeted agents, systemic anticancer therapy, conventional and stereotactic body radiation therapy, and ablative techniques.